In vitro and in vivo evidence demonstrated the role of α-SMA+ CAFs in CCA development and drug resistance; inducing CAF apoptosis reduces cancer cells and metastasis in a syngeneic rat CCA model [124]. Here, ACTA1 is linked to cholangiocarcinoma.